Yvonne McGrath

Companies

• iTeos Therapeutics, Inc.VP, Research and Development Jul 23, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ITiTeos Therapeutics, Inc.0 shares²Aug 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 29, 2025U 46,300 shares of iTeos Therapeutics, Inc.²
• Mar 7, 2025Granted 15,300 shares of iTeos Therapeutics, Inc.³
• Dec 5, 2023Granted 31,000 shares of iTeos Therapeutics, Inc.⁴
• Mar 1, 2022Sold 10,000 shares at $36.76 of iTeos Therapeutics, Inc.⁵
• Mar 1, 2022Exercised options 10,000 shares at $4.24 of iTeos Therapeutics, Inc.⁵